Literature DB >> 10546626

Surgical treatment of osseous metastases in patients with renal cell carcinoma.

H R Dürr1, M Maier, M Pfahler, A Baur, H J Refior.   

Abstract

Forty-five patients who underwent surgical treatment for osseous metastases secondary to renal cell carcinoma between 1980 and 1998 were reviewed. The diagnosis was confirmed histologically in all patients. The mean age of the 34 men was 61.5 +/- 9 years and of the 11 women 55.2 +/- 17.6 years. The most common locations of the metastases were the spine (15 patients), the pelvis (eight patients), and the femur (11 patients). In 21 patients, the renal cell carcinoma was diagnosed when the osseous metastasis was detected. The time from diagnosis of the primary tumor to metastasis in the remaining patients ranged from 0 to 23 years (mean, 3 +/- 5 years). At presentation, 19 patients had a singular lesion. Nine patients had multiple osseous metastases and 17 patients had additional visceral involvement. In seven patients, a wide or radical resection was done; in 35 patients, a palliative procedure was done; and in three patients, only a diagnostic procedure was done. For the whole group, the survival was 49% after 1 year, 39% after 2 years, and 15% after 5 years. Only the extent of the disease and the latency period between primary tumor diagnosis and first detection of osseous metastasis could be identified as independent factors of survival. Nine patients with solitary metastasis to the bone more than 12 months after resection of the primary tumor showed a 5-year survival of 54%.

Entities:  

Mesh:

Year:  1999        PMID: 10546626

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  20 in total

1.  Pilot trial of bone-targeted therapy combining zoledronate with fluvastatin or atorvastatin for patients with metastatic renal cell carcinoma.

Authors:  George E Manoukian; Nizar M Tannir; Eric Jonasch; Wei Qiao; Tamara M Haygood; Shi-Ming Tu
Journal:  Clin Genitourin Cancer       Date:  2011-10-01       Impact factor: 2.872

Review 2.  [Therapy strategies for advanced renal cell carcinoma].

Authors:  M Staehler; N Haseke; G Schöppler; T Stadler; C Adam; C G Stief
Journal:  Urologe A       Date:  2006-01       Impact factor: 0.639

3.  Characterization of a new renal cell carcinoma bone metastasis mouse model.

Authors:  Anne Strube; Elizaveta Stepina; Dominik Mumberg; Arne Scholz; Peter Hauff; Sanna-Maria Käkönen
Journal:  Clin Exp Metastasis       Date:  2010-05-05       Impact factor: 5.150

Review 4.  Acrometastases.

Authors:  Andreas F Mavrogenis; George Mimidis; Zinon T Kokkalis; Eirini-Sofia Karampi; Irene Karampela; Panayiotis J Papagelopoulos; Apostolos Armaganidis
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-09-08

5.  Bone pulsating metastasis due to renal cell carcinoma.

Authors:  Murat Cınar; Alihan Derincek; Belgin Karan; Sercan Akpınar; Cengiz Tuncay
Journal:  Musculoskelet Surg       Date:  2010-04-08

6.  Stereotactic radiosurgery compared with external radiation therapy as a primary treatment in spine metastasis from renal cell carcinoma: a multicenter, matched-pair study.

Authors:  Seil Sohn; Chun Kee Chung; Moon Jun Sohn; Ung-Kyu Chang; Sung Hwan Kim; Jinhee Kim; Eunjung Park
Journal:  J Neurooncol       Date:  2014-05-03       Impact factor: 4.130

Review 7.  [Metastatic disease in long bones : Review of surgical treatment options].

Authors:  Franz Liska; Philipp Schmitz; Norbert Harrasser; Peter Prodinger; Hans Rechl; Rüdiger von Eisenhart-Rothe
Journal:  Unfallchirurg       Date:  2018-01       Impact factor: 1.000

Review 8.  Animal Models of Bone Metastasis.

Authors:  J K Simmons; B E Hildreth; W Supsavhad; S M Elshafae; B B Hassan; W P Dirksen; R E Toribio; T J Rosol
Journal:  Vet Pathol       Date:  2015-05-28       Impact factor: 2.221

Review 9.  [Prognosis-adapted surgical management of bone metastases].

Authors:  S Utzschneider; P Weber; A Fottner; B Wegener; V Jansson; H R Dürr
Journal:  Orthopade       Date:  2009-04       Impact factor: 1.087

10.  Prognostic factors and survival of renal clear cell carcinoma patients with bone metastases.

Authors:  Attila Szendroi; Elek Dinya; Magdolna Kardos; A Marcel Szász; Zsuzsanna Németh; Katalin Ats; János Kiss; Imre Antal; Imre Romics; Miklós Szendroi
Journal:  Pathol Oncol Res       Date:  2009-07-29       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.